Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 2237 entries
Sorted by: Best Match Show Resources per page
Repeated total intravenous anesthesia for a patient with a history of enflurane-induced rhabdomyolysis.

Journal of anesthesia

Suzuki A, Hashiba E, Matsui A, Kubota T, Ishihara H, Matsuki A.
PMID: 28921118
J Anesth. 1997 Sep;11(3):231-233. doi: 10.1007/BF02480044.

No abstract available.

Cite
Suzuki A, Hashiba E, Matsui A, et al. Repeated total intravenous anesthesia for a patient with a history of enflurane-induced rhabdomyolysis. J Anesth. 1997;11(3):231-233doi: 10.1007/BF02480044.
Suzuki, A., Hashiba, E., Matsui, A., Kubota, T., Ishihara, H., & Matsuki, A. (1997). Repeated total intravenous anesthesia for a patient with a history of enflurane-induced rhabdomyolysis. Journal of anesthesia, 11(3), 231-233. https://doi.org/10.1007/BF02480044
Suzuki, Akiko, et al. "Repeated total intravenous anesthesia for a patient with a history of enflurane-induced rhabdomyolysis." Journal of anesthesia vol. 11,3 (1997): 231-233. doi: https://doi.org/10.1007/BF02480044
Suzuki A, Hashiba E, Matsui A, Kubota T, Ishihara H, Matsuki A. Repeated total intravenous anesthesia for a patient with a history of enflurane-induced rhabdomyolysis. J Anesth. 1997 Sep;11(3):231-233. doi: 10.1007/BF02480044. PMID: 28921118.
Copy Download .nbib Format: NLM
Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability.

Experimental and therapeutic medicine

Hattori H, Ishihara M.
PMID: 28450960
Exp Ther Med. 2017 Mar;13(3):1176-1180. doi: 10.3892/etm.2017.4041. Epub 2017 Jan 13.

Platelet-rich plasma (PRP) is blood plasma containing a high number of platelets that release growth factors for wound healing and tissue regeneration. In the present study, the feasibility of improving PRP therapy by using chitosan that exhibits high platelet...

Cite
Hattori H, Ishihara M. Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability. Exp Ther Med. 2017;13(3):1176-1180doi: 10.3892/etm.2017.4041.
Hattori, H., & Ishihara, M. (2017). Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability. Experimental and therapeutic medicine, 13(3), 1176-1180. https://doi.org/10.3892/etm.2017.4041
Hattori, Hidemi, and Ishihara, Masayuki. "Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability." Experimental and therapeutic medicine vol. 13,3 (2017): 1176-1180. doi: https://doi.org/10.3892/etm.2017.4041
Hattori H, Ishihara M. Feasibility of improving platelet-rich plasma therapy by using chitosan with high platelet activation ability. Exp Ther Med. 2017 Mar;13(3):1176-1180. doi: 10.3892/etm.2017.4041. Epub 2017 Jan 13. PMID: 28450960; PMCID: PMC5403699.
Copy Download .nbib Format: NLM
European Survey of Prescriber Understanding of Risks Associated with Retigabine.

Drugs - real world outcomes

Ishihara L, Lewis A, Kolli S, Brickel N.
PMID: 26688787
Drugs Real World Outcomes. 2015;2(4):345-353. doi: 10.1007/s40801-015-0044-3. Epub 2015 Nov 16.

BACKGROUND: We conducted a survey to assess physicians' knowledge and understanding of key risks associated with retigabine.OBJECTIVE: The survey evaluated the effectiveness of the educational plan for retigabine, as specified in the GlaxoSmithKline (GSK) European Risk Management Plan.METHODS: This...

Cite
Ishihara L, Lewis A, Kolli S, et al. European Survey of Prescriber Understanding of Risks Associated with Retigabine. Drugs Real World Outcomes. 2015;2(4):345-353doi: 10.1007/s40801-015-0044-3.
Ishihara, L., Lewis, A., Kolli, S., & Brickel, N. (2015). European Survey of Prescriber Understanding of Risks Associated with Retigabine. Drugs - real world outcomes, 2(4), 345-353. https://doi.org/10.1007/s40801-015-0044-3
Ishihara, Lianna, et al. "European Survey of Prescriber Understanding of Risks Associated with Retigabine." Drugs - real world outcomes vol. 2,4 (2015): 345-353. doi: https://doi.org/10.1007/s40801-015-0044-3
Ishihara L, Lewis A, Kolli S, Brickel N. European Survey of Prescriber Understanding of Risks Associated with Retigabine. Drugs Real World Outcomes. 2015;2(4):345-353. doi: 10.1007/s40801-015-0044-3. Epub 2015 Nov 16. PMID: 26688787; PMCID: PMC4674521.
Copy Download .nbib Format: NLM
Application of high-intensity focused ultrasound for fetal therapy: experimental study using an animal model of lower urinary tract obstruction.

Journal of medical ultrasonics (2001)

Aoki H, Ichizuka K, Ichihara M, Matsuoka R, Hasegawa J, Okai T, Umemura S.
PMID: 27277098
J Med Ultrason (2001). 2013 Apr;40(2):107-10. doi: 10.1007/s10396-012-0398-z. Epub 2012 Sep 08.

OBJECTIVE: The purpose of this study is to investigate whether high-intensity focused ultrasound (HIFU) exposure is able to produce a fistula between the bladder and abdominal wall of a fetus with lower urinary tract obstruction (LUTO).MATERIALS AND METHODS: We...

Cite
Aoki H, Ichizuka K, Ichihara M, et al. Application of high-intensity focused ultrasound for fetal therapy: experimental study using an animal model of lower urinary tract obstruction. J Med Ultrason (2001). 2012;40(2):107-10doi: 10.1007/s10396-012-0398-z.
Aoki, H., Ichizuka, K., Ichihara, M., Matsuoka, R., Hasegawa, J., Okai, T., & Umemura, S. (2013). Application of high-intensity focused ultrasound for fetal therapy: experimental study using an animal model of lower urinary tract obstruction. Journal of medical ultrasonics (2001), 40(2), 107-10. https://doi.org/10.1007/s10396-012-0398-z
Aoki, Hiroko, et al. "Application of high-intensity focused ultrasound for fetal therapy: experimental study using an animal model of lower urinary tract obstruction." Journal of medical ultrasonics (2001) vol. 40,2 (2013): 107-10. doi: https://doi.org/10.1007/s10396-012-0398-z
Aoki H, Ichizuka K, Ichihara M, Matsuoka R, Hasegawa J, Okai T, Umemura S. Application of high-intensity focused ultrasound for fetal therapy: experimental study using an animal model of lower urinary tract obstruction. J Med Ultrason (2001). 2013 Apr;40(2):107-10. doi: 10.1007/s10396-012-0398-z. Epub 2012 Sep 08. PMID: 27277098.
Copy Download .nbib Format: NLM
Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia.

Heart Asia

Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M.
PMID: 27326130
Heart Asia. 2013 Sep 13;5(1):204-9. doi: 10.1136/heartasia-2013-010368. eCollection 2013.

BACKGROUND: Pitavastatin is a statin with strong pleiotropic effects, but the effects of pitavastatin on endothelial cell function (ECF) and both inflammatory cytokines and chemokines have not been fully investigated.MATERIAL AND METHODS: We simultaneously measured brachial artery (BA) flow-mediated...

Cite
Takase B, Hattori H, Tanaka Y, et al. Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia. 2013;5(1):204-9doi: 10.1136/heartasia-2013-010368.
Takase, B., Hattori, H., Tanaka, Y., Nagata, M., & Ishihara, M. (2013). Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia, 5(1), 204-9. https://doi.org/10.1136/heartasia-2013-010368
Takase, Bonpei, et al. "Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia." Heart Asia vol. 5,1 (2013): 204-9. doi: https://doi.org/10.1136/heartasia-2013-010368
Takase B, Hattori H, Tanaka Y, Nagata M, Ishihara M. Pitavastatin subacutely improves endothelial function and reduces inflammatory cytokines and chemokines in patients with hypercholesterolaemia. Heart Asia. 2013 Sep 13;5(1):204-9. doi: 10.1136/heartasia-2013-010368. eCollection 2013. PMID: 27326130; PMCID: PMC4832709.
Copy Download .nbib Format: NLM
Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues.

Bioscience, biotechnology, and biochemistry

Toshima H, Nara S, Ichihara A, Koda Y, Kikuta Y.
PMID: 27392555
Biosci Biotechnol Biochem. 1998;62(4):681-8. doi: 10.1271/bbb.62.681.

Coronafacic acid (1) is an acid component of coronatine, and has been isolated from several pathovars of Pseudomonas syringae. Syntheses of C6-non- and C6-alkyl-substituted analogues of 1 were accomplished via intramolecular 1,6-conjugate addition as the key step. Among them,...

Cite
Toshima H, Nara S, Ichihara A, et al. Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Biosci Biotechnol Biochem. 1998;62(4):681-8doi: 10.1271/bbb.62.681.
Toshima, H., Nara, S., Ichihara, A., Koda, Y., & Kikuta, Y. (1998). Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Bioscience, biotechnology, and biochemistry, 62(4), 681-8. https://doi.org/10.1271/bbb.62.681
Toshima, H, et al. "Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues." Bioscience, biotechnology, and biochemistry vol. 62,4 (1998): 681-8. doi: https://doi.org/10.1271/bbb.62.681
Toshima H, Nara S, Ichihara A, Koda Y, Kikuta Y. Syntheses and Potato Tuber-inducing Activity of Coronafacic Acid Analogues. Biosci Biotechnol Biochem. 1998;62(4):681-8. doi: 10.1271/bbb.62.681. PMID: 27392555.
Copy Download .nbib Format: NLM
In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism.

Bioscience, biotechnology, and biochemistry

Okubo T, Ishihara N, Oura A, Serit M, Kim M, Yamamoto T, Mitsuoka T.
PMID: 27280652
Biosci Biotechnol Biochem. 1992 Jan;56(4):588-91. doi: 10.1271/bbb.56.588.

Effects of tea polyphenol intake (0.4 g/volunteer, 3 times per day, for four weeks) on fecal microflora, bacterial metabolites, and pH were investigated using eight healthy human volunteers. Counts for Clostridium perfringens and other Clostridium spp. were significantly decreased...

Cite
Okubo T, Ishihara N, Oura A, et al. In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism. Biosci Biotechnol Biochem. 1992;56(4):588-91doi: 10.1271/bbb.56.588.
Okubo, T., Ishihara, N., Oura, A., Serit, M., Kim, M., Yamamoto, T., & Mitsuoka, T. (1992). In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism. Bioscience, biotechnology, and biochemistry, 56(4), 588-91. https://doi.org/10.1271/bbb.56.588
Okubo, T, et al. "In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism." Bioscience, biotechnology, and biochemistry vol. 56,4 (1992): 588-91. doi: https://doi.org/10.1271/bbb.56.588
Okubo T, Ishihara N, Oura A, Serit M, Kim M, Yamamoto T, Mitsuoka T. In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism. Biosci Biotechnol Biochem. 1992 Jan;56(4):588-91. doi: 10.1271/bbb.56.588. PMID: 27280652.
Copy Download .nbib Format: NLM
Distal Radius Isoelastic Resurfacing Prosthesis: A Preliminary Report.

Journal of wrist surgery

Ichihara S, Díaz JJ, Peterson B, Facca S, Bodin F, Liverneaux P.
PMID: 26261738
J Wrist Surg. 2015 Aug;4(3):150-5. doi: 10.1055/s-0035-1556855.

Background Here we present a preliminary case series of unicompartmental isoelastic resurfacing prosthesis of the distal radius to treat comminuted articular fractures of osteoporotic elderly patients. Materials and Methods Our study included 12 patients, mean age 76 years, who...

Cite
Ichihara S, Díaz JJ, Peterson B, et al. Distal Radius Isoelastic Resurfacing Prosthesis: A Preliminary Report. J Wrist Surg. 2015;4(3):150-5doi: 10.1055/s-0035-1556855.
Ichihara, S., Díaz, J. J., Peterson, B., Facca, S., Bodin, F., & Liverneaux, P. (2015). Distal Radius Isoelastic Resurfacing Prosthesis: A Preliminary Report. Journal of wrist surgery, 4(3), 150-5. https://doi.org/10.1055/s-0035-1556855
Ichihara, Satoshi, et al. "Distal Radius Isoelastic Resurfacing Prosthesis: A Preliminary Report." Journal of wrist surgery vol. 4,3 (2015): 150-5. doi: https://doi.org/10.1055/s-0035-1556855
Ichihara S, Díaz JJ, Peterson B, Facca S, Bodin F, Liverneaux P. Distal Radius Isoelastic Resurfacing Prosthesis: A Preliminary Report. J Wrist Surg. 2015 Aug;4(3):150-5. doi: 10.1055/s-0035-1556855. PMID: 26261738; PMCID: PMC4530183.
Copy Download .nbib Format: NLM
Chaetoglobosin O and Other Phytotoxic Metabolites from Cylindrocladium floridanum, a Causal Fungus of Alfalfa Black Rot Disease.

Bioscience, biotechnology, and biochemistry

Ichihara A, Katayama K, Teshima H, Oikawa H, Sakamura S.
PMID: 27299410
Biosci Biotechnol Biochem. 1996 Jan;60(2):360-1. doi: 10.1271/bbb.60.360.

Several phytotoxic metabolites, including a novel compound chaetoglobosin O, were isolated from Cylindrocladium floridanum Sobers et Seymore. The structure of chaetoglobosin O, including its absolute configuration, was determined by a spectroscopic analysis and chemical correlation. Purified chaetoglobosins A, C,...

Cite
Ichihara A, Katayama K, Teshima H, et al. Chaetoglobosin O and Other Phytotoxic Metabolites from Cylindrocladium floridanum, a Causal Fungus of Alfalfa Black Rot Disease. Biosci Biotechnol Biochem. 1996;60(2):360-1doi: 10.1271/bbb.60.360.
Ichihara, A., Katayama, K., Teshima, H., Oikawa, H., & Sakamura, S. (1996). Chaetoglobosin O and Other Phytotoxic Metabolites from Cylindrocladium floridanum, a Causal Fungus of Alfalfa Black Rot Disease. Bioscience, biotechnology, and biochemistry, 60(2), 360-1. https://doi.org/10.1271/bbb.60.360
Ichihara, A, et al. "Chaetoglobosin O and Other Phytotoxic Metabolites from Cylindrocladium floridanum, a Causal Fungus of Alfalfa Black Rot Disease." Bioscience, biotechnology, and biochemistry vol. 60,2 (1996): 360-1. doi: https://doi.org/10.1271/bbb.60.360
Ichihara A, Katayama K, Teshima H, Oikawa H, Sakamura S. Chaetoglobosin O and Other Phytotoxic Metabolites from Cylindrocladium floridanum, a Causal Fungus of Alfalfa Black Rot Disease. Biosci Biotechnol Biochem. 1996 Jan;60(2):360-1. doi: 10.1271/bbb.60.360. PMID: 27299410.
Copy Download .nbib Format: NLM
Effect of pre-injury anticoagulant and antiplatelet agents on blood loss in elderly patients with severe trauma.

Acute medicine & surgery

Ohmori T, Kitamura T, Onishi H, Ishihara J, Nojima T, Yamamoto K.
PMID: 29123762
Acute Med Surg. 2015 Aug 27;3(2):114-119. doi: 10.1002/ams2.152. eCollection 2016 Apr.

AIM: It has been widely reported that pre-injury use of anticoagulant and antiplatelet agents can affect traumatic brain injury and the associated risk of mortality, however, the effect of these agents on non-head injury site-related blood loss remains unclear....

Cite
Ohmori T, Kitamura T, Onishi H, et al. Effect of pre-injury anticoagulant and antiplatelet agents on blood loss in elderly patients with severe trauma. Acute Med Surg. 2015;3(2):114-119doi: 10.1002/ams2.152.
Ohmori, T., Kitamura, T., Onishi, H., Ishihara, J., Nojima, T., & Yamamoto, K. (2016). Effect of pre-injury anticoagulant and antiplatelet agents on blood loss in elderly patients with severe trauma. Acute medicine & surgery, 3(2), 114-119. https://doi.org/10.1002/ams2.152
Ohmori, Takao, et al. "Effect of pre-injury anticoagulant and antiplatelet agents on blood loss in elderly patients with severe trauma." Acute medicine & surgery vol. 3,2 (2016): 114-119. doi: https://doi.org/10.1002/ams2.152
Ohmori T, Kitamura T, Onishi H, Ishihara J, Nojima T, Yamamoto K. Effect of pre-injury anticoagulant and antiplatelet agents on blood loss in elderly patients with severe trauma. Acute Med Surg. 2015 Aug 27;3(2):114-119. doi: 10.1002/ams2.152. eCollection 2016 Apr. PMID: 29123762; PMCID: PMC5667378.
Copy Download .nbib Format: NLM
Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of .

Frontiers in neuroscience

Lopatina OL, Furuhara K, Ishihara K, Salmina AB, Higashida H.
PMID: 28566999
Front Neurosci. 2017 May 17;11:266. doi: 10.3389/fnins.2017.00266. eCollection 2017.

Communication consists of social interaction, recognition, and information transmission. Communication ability is the most affected component in children with autism spectrum disorder (ASD). Recently, we reported that the

Cite
Lopatina OL, Furuhara K, Ishihara K, et al. Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of . Front Neurosci. 2017;11:266doi: 10.3389/fnins.2017.00266.
Lopatina, O. L., Furuhara, K., Ishihara, K., Salmina, A. B., & Higashida, H. (2017). Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of . Frontiers in neuroscience, 11266. https://doi.org/10.3389/fnins.2017.00266
Lopatina, Olga L, et al. "Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of ." Frontiers in neuroscience vol. 11 (2017): 266. doi: https://doi.org/10.3389/fnins.2017.00266
Lopatina OL, Furuhara K, Ishihara K, Salmina AB, Higashida H. Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of . Front Neurosci. 2017 May 17;11:266. doi: 10.3389/fnins.2017.00266. eCollection 2017. PMID: 28566999; PMCID: PMC5434149.
Copy Download .nbib Format: NLM
Faecal corticosterone levels of dogs relinquished to a shelter in Japan.

Veterinary record open

Uetake K, Uchida H, Ishihara J, Kushima S, Tanaka T.
PMID: 26457191
Vet Rec Open. 2015 Sep 29;2(2):e000139. doi: 10.1136/vetreco-2015-000139. eCollection 2015.

This study investigated the baseline level of faecal corticosterone in dogs relinquished to a shelter and compared changes in it caused by social events that dogs experienced. Faecal corticosterone was measured to assess the average stress levels of dogs...

Cite
Uetake K, Uchida H, Ishihara J, et al. Faecal corticosterone levels of dogs relinquished to a shelter in Japan. Vet Rec Open. 2015;2(2):e000139doi: 10.1136/vetreco-2015-000139.
Uetake, K., Uchida, H., Ishihara, J., Kushima, S., & Tanaka, T. (2015). Faecal corticosterone levels of dogs relinquished to a shelter in Japan. Veterinary record open, 2(2), e000139. https://doi.org/10.1136/vetreco-2015-000139
Uetake, K, et al. "Faecal corticosterone levels of dogs relinquished to a shelter in Japan." Veterinary record open vol. 2,2 (2015): e000139. doi: https://doi.org/10.1136/vetreco-2015-000139
Uetake K, Uchida H, Ishihara J, Kushima S, Tanaka T. Faecal corticosterone levels of dogs relinquished to a shelter in Japan. Vet Rec Open. 2015 Sep 29;2(2):e000139. doi: 10.1136/vetreco-2015-000139. eCollection 2015. PMID: 26457191; PMCID: PMC4594311.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 2237 entries